Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- White to off-white powder
Properties
- Solvents
- Soluble in water (100mg/ml) or DMSO (10mg/ml).
- Melting Point
- 278 °C - dec.
Category: Building Blocks, Intermediates, Reagents
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD) is a cyclic oligosaccharide containing seven D-(+)-glucopyranose units that is widely used to improve the aqueous solubility of various compounds, especially those containing a phenyl group. The circular arrangement of its glucose units produces a torus-shaped ring configuration in which the CH2 groups and ether linkages of the molecule face the hollow interior, resulting in a nonpolar, hydrophobic cavity and a polar, hydrophilic exterior. When combined in solution with other compounds, the nonpolar aromatic portions of that compound interact with the nonpolar interior of the HP-β-CD molecule, thus isolating the aromatic portion of the molecule from the water and thereby increasing its aqueous solubility. HP-β-CD is a mixture containing HP-β-CD with variable hydroxypropyl group substitutions and is a widely used drug delivery vehicle to improve the stability and bioavailability of bioactive compounds. HP-β-CD is also a cholesterol modifier and has shown anticancer activity.
Synonyms | HBC, HP-&beta,-CD, 2-Hydroxypropyl ethers &beta,-cyclodextrin, (2-Hydroxypropyl)-beta-cyclodextrin |
---|---|
Purity | ≥98% (HPLC) |
Appearance | White to off-white powder |
CAS-Number | 128446-35-5 |
Molecular Formula | C63H112O42 |
Molecular Weight | 1541.54 |
Solvents | Soluble in water (100mg/ml) or DMSO (10mg/ml). |
Melting Point | 278 °C – dec. |
Smiles | O[C@@H]([C@@H]1O)[C@H]2C(O[C@@H]1O[C@@H]([C@H]3O)C(O[C@@H]([C@H]3O)O[C@H]4[C@@H]([C@@H]([C@H](OC4COCC(O)C)O[C@@H]([C@@H]5O)C(O[C@@H]([C@H]5O)O[C@@H]6C(C([C@@H](O[C@@H]6COCC(O)C)O[C@@H]7C(C([C@@H](O[C@@H]7COCC(O)C)O[C@@H]([C@H]8O)C(O[C@@H]([C@H]8O)O2)COCC( |
InChi Key | ODLHGICHYURWBS-RYJYQAAZSA-N |
Shipping | AMBIENT |
Short Term Storage | RT |
Long Term Storage | RT |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at RT. |
Transportation | Not dangerous goods |
References | (1) M.E. Brewster, et al.; Pharm. Res. 8, 792 (1991), (2) T.F. Meert, et al.; Eur. J. Anaesthesiol. 9, 399 (1992), (3) A.E. Christian, et al.; J. Lipid Res. 38, 2264 (1997), (4) J. Peeters, et al.; J. Pharm. Sci. 91, 1414 (2002), (5) V.M. Rao, et al.; Int. J. Pharm. 319, 98 (2006), (6) C.W. Yong, et al.; Pharm. Res. 25, 1092 (2008), (7) B.D. Shewale, et al.; Indian J. Pharm. Sci. 70, 255 (2008), (8) M.E. Brewster, et al.; Eur. J. Pharm. Sci. 34, 94 (2008), (9) T. Loftsson, et al.; Acta. Ophthalmol. 90, 603 (2012), (10) A.R. Katageri & M.A. Sheikh; Int. Res. J. Pharm. 3, 52 (2012), (11) M. Yokoo, et al.; PLoS One 10, e0141946 (2015), (12) A.R.S. Couto, et al.; Materials 11, 1971 (2018) |
InChi | InChI=1S/C63H112O42/c1-22(64)8-85-15-29-50-36(71)43(78)57(92-29)100-51-30(16-86-9-23(2)65)94-59(45(80)38(51)73)102-53-32(18-88-11-25(4)67)96-61(47(82)40(53)75)104-55-34(20-90-13-27(6)69)98-63(49(84)42(55)77)105-56-35(21-91-14-28(7)70)97-62(48(83)41(56)76)103-54-33(19-89-12-26(5)68)95-60(46(81)39(54)74)101-52-31(17-87-10-24(3)66)93-58(99-50)44(79)37(52)72/h22-84H,8-21H2,1-7H3/t22?,23?,24?,25?,26?,27?,28?,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-/m1/s1 |
Quantity | 25 g, 100 g, Bulk |